NCT04919603

Brief Summary

It is an open-label, parallel-group, randomized controlled clinical trial, which is designed to enroll people with different glucose metabolism status who are also overweight or obese, including people with normal glucose metabolism, pre-diabetes patients and newly diagnosed type 2 diabetes patients. The patients are randomized to an enhanced physical activity intervention (high-intensity interval training exercise prescription combined with resistance training) or standard education group (diabetes health education only, including lifestyle education and guidance) for 12 weeks. This trial intends to compare the influence of enhanced physical activity treatment with that of a standard education on liver steatosis, serum glucose and lipids level, insulin sensitivity, cardiovascular metabolic parameters, metabolic molecules, and gut microbiota profile et al.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 9, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

June 15, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2023

Completed
Last Updated

June 9, 2021

Status Verified

June 1, 2021

Enrollment Period

12 months

First QC Date

April 22, 2021

Last Update Submit

June 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in liver steatosis quantified by MRI-PDFF (percentage)

    12 weeks

Secondary Outcomes (30)

  • Change in liver steatosis quantified by MRI-PDFF (percentage)

    1 year

  • Change in the level of fasting blood glucose (mmol/l)

    12 weeks and 1 year

  • Change in the level of plasma glucose of 2 hours post glucose-load (mmol/l)

    12 weeks and 1 year

  • Change in the level of HbA1c (percentage)

    12 weeks and 1 year

  • Change in body mass index (BMI)

    12 weeks and 1 year

  • +25 more secondary outcomes

Study Arms (2)

Enhanced physical activity group

EXPERIMENTAL

the participants will take high-intensity exercise in accordance with High Intensity Interval Training (HIIT) prescriptions, with maximum heart rate and relative maximal oxygen uptake monitored. They will take both aerobic and resistance training exercise consecutively, and total training time will be expected to reach at least 150 minutes per week.

Behavioral: Enhanced physical activity intervention

Standard education group

EXPERIMENTAL

the participants will receive no extra intervention but diabetes health education, which will be carried out in large classrooms, in groups, and over the telephone. The education is mainly consisted of instructions on diabetes prevention according to \< Guidelines for prevention and treatment of type 2 diabetes in China (2017 edition)telephone. The education is mainly consisted of instructions on diabetes prevention according to \< Guidelines for prevention and treatment of type 2 diabetes in China (2017 edition)\>.

Behavioral: Standard education

Interventions

the participants will take high-intensity exercise in accordance with High Intensity Interval Training (HIIT) prescriptions, with maximum heart rate and relative maximal oxygen uptake monitored. They will take both aerobic and resistance training exercise consecutively, and total training time will be expected to reach at least 150 minutes per week.

Enhanced physical activity group

the participants will receive no extra intervention but diabetes health education, which will be carried out in large classrooms, in groups, and over the telephone. The education is mainly consisted of instructions on diabetes prevention according to \< Guidelines for prevention and treatment of type 2 diabetes in China (2017 edition)

Standard education group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women aged 18-65 years;
  • Normal glucose metabolism or pre-diabetes or newly diagnosed type 2 diabetes
  • Normal glucose metabolism:
  • FBG\<5.6mmol/L and
  • h-PG\<7.8mmol/L and
  • HbA1c\<5.7%;
  • Pre-diabetes:
  • mmol/L ≤ FBG ≤ 6.9mmol/L and/or
  • mmol/L ≤ 2h-PG ≤ 11.0mmol/L and/or
  • % ≤ HbA1c ≤ 6.4%;
  • Newly diagnosed diabetes:
  • o Duration of type 2 diabetes is less than 5 years;
  • No insulin treatment;
  • Kg/m2 ≤ Body mass index (BMI) \<40 Kg/m2;

You may not qualify if:

  • Eligibility Minimum Age: 18 Years Maximum Age: 65 Years Sex: All Gender Based: No Accepts Healthy Volunteers: No
  • Men and women aged 18-65 years;
  • Normal glucose metabolism or pre-diabetes or newly diagnosed type 2 diabetes
  • Normal glucose metabolism:
  • FBG\<5.6mmol/L and
  • h-PG\<7.8mmol/L and
  • HbA1c\<5.7%;
  • Pre-diabetes:
  • mmol/L ≤ FBG ≤ 6.9mmol/L and/or
  • mmol/L ≤ 2h-PG ≤ 11.0mmol/L and/or
  • % ≤ HbA1c ≤ 6.4%;
  • Newly diagnosed diabetes:
  • o Duration of type 2 diabetes is less than 5 years;
  • No insulin treatment;
  • Kg/m2 ≤ Body mass index (BMI) \<40 Kg/m2;
  • +24 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shanghai Institute of Endocrine and Metabolic Diseases

Shanghai, Shanghai Municipality, 200025, China

NOT YET RECRUITING

The Third People's Hospital of Datong City

Datong, Shanxi, China

RECRUITING

MeSH Terms

Conditions

OverweightObesityMotor Activity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Central Study Contacts

Yufang Bi, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 22, 2021

First Posted

June 9, 2021

Study Start

June 15, 2021

Primary Completion

May 30, 2022

Study Completion

May 30, 2023

Last Updated

June 9, 2021

Record last verified: 2021-06

Locations